🇺🇸 PF-06939999 in combination with docetaxel in United States

PF-06939999 in combination with docetaxel (pf-06939999-in-combination-with-docetaxel) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

PF-06939999 in combination with docetaxel in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United States

Frequently asked questions

Is PF-06939999 in combination with docetaxel approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for PF-06939999 in combination with docetaxel in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.